Tsimberidou AM, Beer PA, Cartwright CA, Haymaker C, et al. Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors. Clin Cancer Res 2021;27:3584-3594.
PMID: 33947698